Y-mAbs TherapeuticsYMAB
那斯達克 · USD
8.51
-0.01
(-0.12%)
收盤 08/09 03:58 (UTC+8)
盤後
8.52
+0.01
(+0.12%)
08/09 03:58 (UTC+8)
Y-mAbs TherapeuticsYMAB
8.51
-0.01
(-0.12%)
財務數據
損益表
- 0.31
- 0.20
- 0.21
- 0.20
- 0.23
- 0.20
- 0.23
- 0.18
- 0.26
- 0.21
- 150.83
- -35.60
- 2.47
- -1.43
- 14.22
- -14.69
- 14.38
- -19.02
- 43.52
- -21.10
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 20,904 | 26,495 | 18,461 | 22,798 | 19,931 | 23,363 | 20,454 | 20,751 | 20,251 | 31,447 |
營業成本 | 3,001 | 7,592 | 2,248 | 3,064 | 2,147 | 2,039 | 2,645 | 4,649 | 2,083 | 2,020 |
營業毛利 | 17,903 | 18,903 | 16,213 | 19,734 | 17,784 | 21,324 | 17,809 | 16,102 | 18,168 | 29,427 |
營業費用 | 24,446 | 24,839 | 24,781 | 29,523 | - | 24,523 | 25,558 | 23,325 | 25,669 | 30,580 |
研發費用 | 11,359 | 12,214 | 11,168 | 12,341 | 13,267 | 13,388 | 15,358 | 12,055 | 13,418 | 19,787 |
推銷及管理費用 | 13,087 | 12,625 | 13,613 | 17,182 | 11,425 | 11,135 | 10,200 | 11,270 | 12,251 | 10,793 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -6,543 | -5,936 | -8,568 | -9,789 | -6,908 | -3,199 | -7,749 | -7,223 | -7,501 | -1,153 |
其他收入及費用 | 1,352 | -1,606 | 1,916 | 640 | 439 | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -5,191 | -7,542 | -6,652 | -9,149 | -6,469 | -793 | -7,560 | -6,123 | -6,390 | 1,157 |
所得稅 | 5 | -752 | 346 | 100 | 160 | 195 | 187 | 179 | - | - |
稅後純益 | -5,196 | -6,790 | -6,998 | -9,249 | -6,629 | -988 | -7,747 | -6,302 | -6,390 | 1,157 |
基本每股稅後盈餘(元) | -0.12 | -0.15 | -0.16 | -0.21 | -0.15 | - | -0.18 | -0.14 | -0.15 | 0.03 |
稀釋每股稅後盈餘(元) | -0.12 | -0.15 | -0.16 | -0.21 | -0.15 | -0.02 | -0.18 | -0.14 | -0.15 | 0.02 |
基本平均股數(千股) | 45104.00 | 44875.00 | 44626.00 | 44022.00 | 43779.00 | - | 43620.00 | 43663.00 | 43671.00 | 43668.00 |
稀釋平均股數(千股) | 45104.00 | 44875.00 | 44626.00 | 44022.00 | 43779.00 | - | 43620.00 | 43663.00 | 43671.00 | 44692.00 |
還原基本每股稅後盈餘(元) | -0.12 | -0.15 | -0.16 | -0.21 | -0.15 | - | -0.18 | -0.14 | -0.15 | 0.03 |
還原稀釋每股稅後盈餘(元) | -0.12 | -0.15 | -0.16 | -0.21 | -0.15 | -0.02 | -0.18 | -0.14 | -0.15 | 0.02 |
還原基本平均股數(千股) | 45,104 | 44,875 | 44,626 | 44,022 | 43,779 | - | 43,620 | 43,663 | 43,671 | 43,668 |
還原稀釋平均股數(千股) | 45,104 | 44,875 | 44,626 | 44,022 | 43,779 | - | 43,620 | 43,663 | 43,671 | 44,692 |
EBITDA(千元) | -5,120 | -7,440 | -6,531 | -8,996 | -6,310 | -632 | -7,392 | -5,899 | -6,208 | 1,387 |